0000899243-17-023972.txt : 20171010
0000899243-17-023972.hdr.sgml : 20171010
20171010195702
ACCESSION NUMBER: 0000899243-17-023972
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171006
FILED AS OF DATE: 20171010
DATE AS OF CHANGE: 20171010
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Louks Ronald Allen
CENTRAL INDEX KEY: 0001706849
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37792
FILM NUMBER: 171131635
MAIL ADDRESS:
STREET 1: C/O NANTHEALTH, INC.
STREET 2: 9920 JEFFERSON BLVD.
CITY: CULVER CITY
STATE: CA
ZIP: 90232
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NantHealth, Inc.
CENTRAL INDEX KEY: 0001566469
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
IRS NUMBER: 273019889
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9920 JEFFERSON BLVD
CITY: CULVER CITY
STATE: CA
ZIP: 90232
BUSINESS PHONE: (310) 853-7888
MAIL ADDRESS:
STREET 1: 9920 JEFFERSON BLVD
CITY: CULVER CITY
STATE: CA
ZIP: 90232
FORMER COMPANY:
FORMER CONFORMED NAME: Nant Health, LLC
DATE OF NAME CHANGE: 20130108
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-10-06
0
0001566469
NantHealth, Inc.
NH
0001706849
Louks Ronald Allen
C/O NANTHEALTH, INC.
9920 JEFFERSON BLVD.
CULVER CITY
CA
90232
0
1
0
0
Chief Operating Officer
Common Stock
2017-10-06
4
M
0
40000
A
40000
D
Common Stock
2017-10-06
4
F
0
13180
4.28
D
26820
D
Common Stock
2017-10-06
4
S
0
26820
4.28
D
0
D
Restricted Stock Units
2017-10-06
4
M
0
40000
0.00
D
Common Stock
40000
120000
D
Each restricted stock unit ("RSU") is the economic equivalent of one share of NantHealth, Inc. common stock.
Subject to the Reporting Person's continuing to be a service provider (as defined in the 2016 Equity Incentive Plan) through each applicable vesting date, 40,000 RSUs shall vest on October 6, 2017, with the remaining 120,000 RSUs to vest monthly in equal amounts for 12 months, beginning on November 6, 2017. Upon vesting, the issuer will withhold shares sufficient to satisfy tax withholding obligations; the issuer will then be responsible for remitting a cash payment for the related withholding taxes; and the issuer will issue to the Reporting Person a net lower number of shares. In addition, upon vesting, the issuer and the Reporting Person have agreed that the issuer will repurchase the remaining shares at the then current market value.
Pursuant to the terms of the grant, the Issuer repurchased the shares at a price per share equal to the closing price on the date of vesting
/s/ Charles Kim, as Attorney-in-Fact
2017-10-10